Dr David Herrmann
Dr David Herrmann completed his Diploma and PhD studies in the field of Developmental Biology in Freiburg, Germany. Due to the strong similarities between embryonic development and cancerogenesis he became interested in joining Dr Paul Timpson’s research group to work on invasion and metastasis, moving to Sydney to join the Garvan Institute of Medical Research in 2012.
Awards
- 2016Young Garvan Finalist: https://www.youtube.com/watch?v=6DPuo5aphU0
- 2010Traveling grant from the CDB Riken Center - Japan to attend the meeting “Frontiers in Organogenesis” - Kobe
- 2009Member of the GRK1104 “From Cells to Organs: Molecular Mechanisms of Organogenesis”
- 2008Alumni-Diploma Award - University of Freiburg - Faculty of Biology
Selected publications
See all publications- 2026Nature Communications10.1038/s41467-026-72302-1
Using rotational integration of oblique interferometric scattering to track axial spatiotemporal responses of tubular membrane protrusions.
- 2026Nature Communications10.1038/s41467-026-69398-w
Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer.
- 2025Cell Reports10.1016/j.celrep.2025.115691
ER stress disrupts insulin release in murine models of type 2 diabetes by impairing retromer action and constitutive secretion.
- 2025Science Advances10.1126/sciadv.adq4416
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
- 2024European Journal of Immunology10.1002/eji.202451215
Bystander Expression of Atypical Chemokine Receptor 2 Protects T Cells from Chemoattraction towards Cancer-Associated Fibroblasts.